Perspectum Announces Executive Leadership Changes
Dr. Rajarshi Banerjee is no longer with Perspectum. The Board has appointed the Company’s Chief Operating Officer, Dr. Rexford Newbould, as Interim Chief …
5 Jan 2026
Perspectum and Avant Santéannounce strategic partnership to strengthen quantitative imaging for metabolic and liver research in Mexico and Latin America
Boston, MA and Monterrey, Mexico - 17 December 2025. Perspectum, a global medical technology company advancing quantitative imaging for metabolic, liver and mu…
5 Jan 2026
Perspectum and InHealth announce national diagnostics partnership to boost Oxford CDC capacity and widen access to advanced MRI across the UK
Perspectum and InHealth have announced a new national diagnostics partnership that will significantly expand access to advanced MRI and increase capacity at th…
2 Dec 2025
New analysis shows corrected T1 (cT1) is the most appropriate diagnosis and monitoring tool for widespread adoption of resmetirom treatment in the United States
WASHINGTON, D.C. – SEPTEMBER 03, 2025 – (BUSINESS WIRE) – Newly published economic modeling concludes that Perspectum’s proprietary biomarker cT1 may h…
3 Sep 2025
UK Biobank Completes World’s Largest Human Imaging Study
UK Biobank has marked the successful completion of the world’s largest human imaging study, with over 60,000 participants scanned as part of its landmark res…
15 Aug 2025
Marea Therapeutics Publishes Phase 2 Trial Results in The Lancet
Perspectum is proud to see one of our commercial collaborations reach a major milestone, with results from an early-phase clinical trial now published in The L…
8 Jul 2025
Major Study Shows Liver Health Measured with cT1 Predicts Clinical Outcomes
WASHINGTON – Nature Medicine today published a study showing that Perspectum’s iron corrected T1, or cT1, predicts liver-related and cardiac outcomes, incl…
7 May 2025
New Multinational Study Shows MRI is Cost-Effective in the Diagnosis and Management of Steatotic Liver Disease
WASHINGTON, D.C. – MARCH 18, 2025 – (BUSINESS WIRE) – Perspectum today released the results of a multinational study showing that LiverMultiScan can redu…
18 Mar 2025
Perspectum Awarded New FDA Grant to Evaluate Biomarker for Rare Disease Drug Development
WASHINGTON, D.C. -- November 14, 2024 – (BUSINESS WIRE) -- Perspectum, a leader in medical imaging quantification techniques, today announced that it has bee…
14 Nov 2024
CoverScan, Perspectum’s multi-organ MRI technology, has been nominated for the 2024 Prix Galien USA award for Best Digital Health Solution.
CoverScan, Perspectum’s multi-organ MRI technology, has been nominated for the 2024 Prix Galien USA award for Best Digital Health Solution. Perspectum is amo…
30 Oct 2024
New Published Data Show Reproducibility and Utility of Perspectum’s MRI in Patients With Metabolic Liver Disease
WASHINGTON & OXFORD, England (BUSINESS WIRE) Perspectum announced two research studies that were recently published, bringing hope to people withmetabolic …
26 Sep 2024
Dr Rajarshi Banerjee joins Amrita Sarkar, Principal Healthcare and Life Sciences Startups Business Development manager in this episode of the AWS Health Innovation Podcast.
In this episode of the AWS Health Innovation Podcast, Amrita Sarkar, Principal Healthcare and Life Sciences Startups Business Development Manager at Amazo…
27 Aug 2024